NCT01831947View on ClinicalTrials.gov

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Macular Degeneration
Interventions
BIOLOGICAL

Ranibizumab

Trial Locations (1)

37075

Dept. of Ophthalmology, University Medical Center Goettingen, Göttingen

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

University Medical Center Goettingen

OTHER

lead

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

OTHER